Bahrain-based Global asset manager Investcorp is investing in Chinese software and supply chain management services startup Linkedcare, as it intends to further expand its Asian portfolio of investments.
Investcorp has signed several agreements to invest in the company that offers services to China’s fast-growing dental and medical aesthetics industry.
According to the statement, the latest Series D round of funding was led by Investcorp with co-investors Matrix Partners China, Lightspeed China Partners, So-Young International, Jinding Capital, and Sheng Ye Capital.
Mr. Duncan Zheng, MD and Head of Private Equity China at Investcorp, who will join the Board of Directors at Linkedcare said, “Linkedcare is a phenomenal innovator in China’s dental SaaS industry and we are very honored to partner with Mr. Zhijia Wu (CEO and Co-Founder of Linkedcare) and his excellent management team to further strengthen the Company’s leadership position through capital and value-added access to our global resources and sector expertise.”
Hazem Ben-Gacem Co-CEO – Investcorp
“We are pleased to lead this new round of investment into Linkedcare. China is experiencing strong demand in the dental, beauty and other consumer medical areas underpinned by secular growth in its economy and demographics and we look forward to being part of their growth trajectory. As part of our investment strategy, we have been actively growing our presence in Asia over the past years and this is yet another milestone that we have reached as we continue to advance our diversification journey.”
Founded in 2015, Linkedcare currently serves more than 30,000 dental and medical aesthetic clinics in the mid-to-high-end segment with complete SaaS solutions covering standalone and chain management, outpatient and inpatient CRM, electronic medical records, inventory, and sales management, financial reporting, insurance payment, and so on.
Last year, Investcorp launched a new platform dedicated to investing in high-quality healthcare firms in China. Linkedcare marks Investcorp’s fourth investment in China’s fast-growing healthcare sector over the last 12 months, including KindStar, China’s leading independent medical esoteric testing group; Lu DaoPei, the world’s leading blood oncology hospital group; and WeDoctor, one of China’s largest digital health services platforms, as per the company statement.
